Keyphrases
Pancreatic Neuroendocrine Tumors (pNETs)
100%
Von Hippel-Lindau Disease
61%
Neuroendocrine Tumor
57%
Tumor
56%
Cushing's Syndrome
51%
Pheochromocytoma
44%
Multiple Endocrine Neoplasia Type 1 (MEN1)
37%
Confidence Interval
37%
Odds Ratio
36%
Carney Complex
32%
Hypopituitarism
32%
68Ga-DOTATATE
32%
Von Hippel-Lindau
29%
DOTATATE
27%
Etiology
27%
Cushing's Disease
26%
All-cause Mortality
26%
Germ Cells
25%
Obesity
24%
Adenoma
24%
Pituitary Adenoma
23%
Prognostic Factors
23%
Adrenal Cushing Syndrome
23%
Hazard Ratio
22%
Disease Progression
22%
Genetic Modification
21%
Prolactin
20%
Plasma Cortisol
20%
Prognostic Utility
20%
Multivariable
20%
Paraganglioma
20%
Patient Management
20%
Pancreatic NET
19%
Macroprolactinoma
18%
Working Diagnosis
18%
Pediatric
17%
Primary Hyperparathyroidism (pHPT)
17%
Systemic Metabolism
17%
Hyperglycemia
17%
Blood Glucose
16%
Pathogenic Variants
16%
High Risk
16%
Endoplasmic Reticulum Stress (ER stress)
16%
Erdheim-Chester Disease
16%
Gene mutation
16%
Prognostic Marker
16%
Endogenous Cushing's Syndrome
16%
Cortisol Measurement
16%
Intercellular Transmission
16%
Coagulation Profile
16%
Medicine and Dentistry
Disease
90%
Pancreas Islet Cell Tumor
72%
Neuroendocrine Tumor
68%
Neoplasm
65%
Cushing Syndrome
62%
Von Hippel-Lindau Disease
44%
Hydrocortisone
40%
Carney Complex
32%
Gallium 68
32%
Odds Ratio
31%
Pheochromocytoma
30%
Pituitary Adenoma
26%
Prevalence
26%
Hypopituitarism
25%
Prognostic Factor
23%
Disease Exacerbation
21%
Adenoma
21%
Gene Mutation
20%
Paraganglioma
20%
Hazard Ratio
20%
Surgery
18%
Computer Assisted Tomography
18%
Maturity Onset Diabetes of the Young
17%
Urinary System
17%
Multiple Endocrine Neoplasia Type I
17%
Primary Hyperparathyroidism
17%
Nesidioblastosis
17%
All Cause Mortality
17%
Hyperglycemia
17%
Body Mass Index
16%
Erdheim-Chester Disease
16%
Prolactinoma
16%
Endoplasmic Reticulum Stress
16%
Family History
15%
Hypothalamic-Pituitary-Adrenal Axis
15%
Hypothyroidism
14%
Pediatrics Patient
14%
Corticotropin
13%
Positron Emission Tomography-Computed Tomography
13%
Somatics
13%
Diabetes Mellitus
13%
Genetic Screening
12%
Multiple Endocrine Neoplasia
12%
Adrenal Gland
12%
Radionuclide Therapy
12%
Peptide Receptor
12%
Hypercortisolism
12%
Diabetes
11%
Endocrine Tumor
11%
Malignant Neoplasm
11%
